Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19
Michael E. Bowdish, Christina E. Barkauskas, Jessica Overbey, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 207, Iss. 3, pp. 261-270
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Vascular leak in sepsis: physiological basis and potential therapeutic advances
Ross R. McMullan, Daniel F. McAuley, Cecilia M. O’Kane, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 19
The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
Shou Zhen Wang, Yiming Li, Bingqing Wang, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 34
Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup
Huikang Xu, Shiying Sheng, Weiwei Luo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
Douglas E. Gladstone, Franco R. D’Alessio, Christopher Howard, et al.
Blood Advances (2023) Vol. 7, Iss. 13, pp. 3075-3079
Open Access | Times Cited: 23
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial
Tiantian Li, Bo Zhang, Hui Fang, et al.
EBioMedicine (2023) Vol. 92, pp. 104600-104600
Open Access | Times Cited: 22
Investigational pharmacological agents for the treatment of ARDS
Katyayini Aribindi, Michelle Lim, Satyan Lakshminrusimha, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 3, pp. 243-277
Closed Access | Times Cited: 9
Acute respiratory distress syndrome
Katherine D. Wick, Lorraine B. Ware, Michael A. Matthay
BMJ (2024), pp. e076612-e076612
Closed Access | Times Cited: 9
ISCT MSC Committee Statement on the US FDA Approval of Allogenic Bone-Marrow Mesenchymal Stromal Cells
Katarina Le Blanc, Francesco Dazzi, Karen English, et al.
Cytotherapy (2025)
Closed Access | Times Cited: 1
Safety and efficacy of human umbilical cord-derived mesenchymal stem cells in COVID-19 patients: A real-world observation
Siyu Wang, Tao Yang, Tiantian Li, et al.
Chinese Medical Journal (2025)
Open Access | Times Cited: 1
Mesenchymal stem cells biological and biotechnological advances: Implications for clinical applications
Jana Pharoun, Jana Berro, Jeanine Sobh, et al.
European Journal of Pharmacology (2024) Vol. 977, pp. 176719-176719
Closed Access | Times Cited: 7
Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific Committee
Kevin P. Robb, Jacques Galipeau, Yufang Shi, et al.
Cytotherapy (2023) Vol. 26, Iss. 5, pp. 413-417
Open Access | Times Cited: 14
Acute respiratory distress syndrome (ARDS): from mechanistic insights to therapeutic strategies
Rongli Xie, Dan Tan, Boke Liu, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial
Mengqi Yuan, Le Song, Ze-Rui Wang, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Mesenchymal stem cells alleviate idiopathic pneumonia syndrome by facilitating M2 polarization via CCL2/CCR2 axis and further inducing formation of regulatory CCR2 + CD4 + T cells
Chao Xue, Wei Liu, Yuan Li, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies
Wen Ma, Songling Tang, Yao Peng, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial
Roberto Tonelli, Francesca Pischiutta, Francesca Elice, et al.
Cytotherapy (2025)
Open Access
Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial
Ellen Gorman, Jennifer Rynne, Hannah J. Gardiner, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 3, pp. 256-269
Open Access | Times Cited: 12
Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?
Gerard F. Curley, Cecilia M. O’Kane, Daniel F. McAuley, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 209, Iss. 7, pp. 789-797
Open Access | Times Cited: 4
Pathophysiological mechanisms of ARDS: a narrative review from molecular to organ-level perspectives
Kaihuan Zhou, Qianqian Qin, Junyu Lu
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic
Xiaoli Zhuang, Yu Jiang, Xiaofang Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Mesenchymal Stem Cells on Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jinlv Qin, Guizuo Wang, Dong Han
Stem Cell Reviews and Reports (2024) Vol. 20, Iss. 4, pp. 931-937
Closed Access | Times Cited: 3
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue–derived MSCs for research purposes
Sowmya Viswanathan, Katarina Le Blanc, Rachele Ciccocioppo, et al.
Cytotherapy (2023) Vol. 25, Iss. 8, pp. 803-807
Open Access | Times Cited: 8
dCas9-Based PDGFR–β Activation ADSCs Accelerate Wound Healing in Diabetic Mice through Angiogenesis and ECM Remodeling
Yumeng Li, Deyong Li, Lu You, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5949-5949
Open Access | Times Cited: 7
Effect and safety of mesenchymal stem cells for patients with COVID‐19: Systematic review and meta‐analysis with trial sequential analysis
Zhijing Zhang, Shuai Shao, Xuefeng Liu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Open Access | Times Cited: 7
Mesenchymal Stem Cells in the Treatment of COVID-19
Bei-Cyuan Guo, Kang‐Hsi Wu, Chun‐Yu Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14800-14800
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top